Copyright © Inderes 2011 - present. All rights reserved.

I-tech

100.5

 

SEK

 

+0.5 %

Less than 1K followers

ITECH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

+0.5%
+20.22%
+26.42%
+73.28%
+102.62%
+101.81%
+220.06%
-1.95%
+307.46%

I-tech operates in marine technology. The company conducts research and development of substances that inhibit marine growth on ship hulls. In addition, the products can be used for various marine installations in fish farming and offshore. Customers are found in the marine paint industry and among other actors in the shipping industry. I-Tech was founded in 2000 and today has its headquarter in Mölndal.

Read more
Market cap
1.2B SEK
Turnover
1.23M SEK
Revenue
179.45M
EBIT %
25.35 %
P/E
30.45
Dividend yield-%
1 %
Financial calendar
22/8
2025

Interim report Q2'25

17/10
2025

Interim report Q3'25

5/2
2026

Annual report '25

ShowingAll content types
Third party research

I-tech: Announce one year extension of Selektope approval - ABG

Q1 revenues 3% below, EBIT DKK -1m vs. ABGSCe DKK 11m FY'25 guidance maintained, as expected Consensus to lower '25e EBITDA by ~10% on Q1 miss Q1 revenues 3% below, EBIT DKK -1m vs. ABGSCe DKK 11m North Media's Q1 revenues of DKK 311m came in 3% below...

I-tech

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Third party research

I-tech: The winning formula continues to unfold - ABG

Strong Q1 sales of SEK 57m, +49% y-o-y '25e-'27e sales and EBIT up 5-6% and 9%, respectively Growth in market share should overshadow market uncertainty The growth journey continues I-Tech reported strong sales of SEK 57m (+9% vs. ABGSCe, +49% y-o-y)...

I-tech
Third party research

I-tech: Even stronger growth than expected - ABG

Sales +9% and EBIT +14% vs. ABGSCe Expect cons. to raise '25e-'27e sales by ~3-4% USD/SEK movements expected to weigh on gross margin Another quarter of strong growth Sales came in at SEK 57m (+9% vs. ABGSCe 52m, +10% vs. cons. 52m), +49% y-o-y (+48%...

I-tech
Third party research

I-tech: FX weighing on '25e-'27e - ABG

Report out 8 May at 08:00 CEST Q1e: sales of SEK 52m +37% y-o-y, adj. EBIT of SEK 17m (10m) '25e-'27e sales down 8-11% on FX movements Q1 expectations For Q1, we estimate sales of SEK 52m, up 37% y-o-y (+33% organic, +4% FX). Although Q4'24 was a strong...

I-tech
Third party research

I-tech: Ending the year on a high note - ABG

Q4: Sales SEK 58m, +129% y-o-y, EBIT margin 29% '25e-'26e sales up 10-12% and EBIT adj. up by 18-19% Customer diversification driving growth Another solid quarter I-Tech delivered strong Q4 results and reported sales of SEK 58m, up +129% y-o-y (+120%...

I-tech
Third party research

I-tech: A strong beat on all lines - ABG

Sales +36% and EBIT +82% vs. ABGSCe Expect cons. to raise '25e-'26e sales by ~15% Overall a strong beat across the board Strong Q4 report I-Tech delivered higher than expected sales of SEK 58m (+36% vs. ABGSCe 42m) +129% y-o-y (+120% org, +9% FX). EBIT...

I-tech
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.